Reply to "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma"

Clin Mol Hepatol. 2025 Jan 6. doi: 10.3350/cmh.2024.1171. Online ahead of print.
No abstract available